Pamela Lockyer1, Hua Mao1, Qiying Fan1, Luge Li1, Li-Yuan Yu-Lee1, N Tony Eissa1, Cam Patterson1, Liang Xie1, Xinchun Pi2. 1. From the Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill (P.L.); Department of Medicine, Section of Athero & Lipo, Cardiovascular Research Institute (H.M., Q.F., L.L., L.X., X.P.), Departments of Molecular and Cellular Biology and Medicine, Section of Immunology Allergy and Rheumatology, Integrative Molecular and Biomedical Sciences (L.Y.Y.L.), and Departments of Medicine and Pathology and Immunology (N.T.E.), Baylor College of Medicine, Houston, TX; and New York-Presbyterian Hospital, New York (C.P.). 2. From the Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill (P.L.); Department of Medicine, Section of Athero & Lipo, Cardiovascular Research Institute (H.M., Q.F., L.L., L.X., X.P.), Departments of Molecular and Cellular Biology and Medicine, Section of Immunology Allergy and Rheumatology, Integrative Molecular and Biomedical Sciences (L.Y.Y.L.), and Departments of Medicine and Pathology and Immunology (N.T.E.), Baylor College of Medicine, Houston, TX; and New York-Presbyterian Hospital, New York (C.P.). xpi@bcm.edu.
Abstract
OBJECTIVE: Bacterial endotoxin (lipopolysaccharide)-mediated sepsis involves dysregulated systemic inflammation, which injures the lung and other organs, often fatally. Vascular endothelial cells act as both targets and mediators of lipopolysaccharide-induced inflammatory responses. Dysfunction of endothelium results in increases of proinflammatory cytokine production and permeability leakage. BMPER (bone morphogenetic protein-binding endothelial regulator), an extracellular modulator of bone morphogenetic protein signaling, has been identified as a vital component in chronic endothelial inflammatory responses and atherosclerosis. However, it is unclear whether BMPER also regulates inflammatory response in an acute setting such as sepsis. To address this question, we investigated the role of BMPER during lipopolysaccharide-induced acute lung injury. APPROACH AND RESULTS: Mice missing 1 allele of BMPER (BMPER+/- mice used in the place of BMPER-/- mice that die at birth) were used for lipopolysaccharide challenge. Lipopolysaccharide-induced pulmonary inflammation and injury was reduced in BMPER+/- mice as shown by several measures, including survival rate, infiltration of inflammatory cells, edema, and production of proinflammatory cytokines. Mechanistically, we have demonstrated that BMPER is required and sufficient for the activation of nuclear factor of activated T cells c1. This BMPER-induced nuclear factor of activated T cells activation is coordinated by multiple signaling pathways, including bone morphogenetic protein-independent low-density lipoprotein receptor-related protein 1-extracellular signal-regulated kinase activation, calcineurin signaling, and low-density lipoprotein receptor-related protein 1β-mediated nuclear factor 45 nuclear export in response to BMPER treatment. CONCLUSIONS: We conclude that BMPER plays a pivotal role in pulmonary inflammatory response, which provides new therapeutic options against sepsis shock. The new signaling pathway initiated by BMPER/low-density lipoprotein receptor-related protein 1 axis broadens our understanding about BMPER's role in vascular homeostasis.
OBJECTIVE: Bacterial endotoxin (lipopolysaccharide)-mediated sepsis involves dysregulated systemic inflammation, which injures the lung and other organs, often fatally. Vascular endothelial cells act as both targets and mediators of lipopolysaccharide-induced inflammatory responses. Dysfunction of endothelium results in increases of proinflammatory cytokine production and permeability leakage. BMPER (bone morphogenetic protein-binding endothelial regulator), an extracellular modulator of bone morphogenetic protein signaling, has been identified as a vital component in chronic endothelial inflammatory responses and atherosclerosis. However, it is unclear whether BMPER also regulates inflammatory response in an acute setting such as sepsis. To address this question, we investigated the role of BMPER during lipopolysaccharide-induced acute lung injury. APPROACH AND RESULTS:Mice missing 1 allele of BMPER (BMPER+/- mice used in the place of BMPER-/- mice that die at birth) were used for lipopolysaccharide challenge. Lipopolysaccharide-induced pulmonary inflammation and injury was reduced in BMPER+/- mice as shown by several measures, including survival rate, infiltration of inflammatory cells, edema, and production of proinflammatory cytokines. Mechanistically, we have demonstrated that BMPER is required and sufficient for the activation of nuclear factor of activated T cells c1. This BMPER-induced nuclear factor of activated T cells activation is coordinated by multiple signaling pathways, including bone morphogenetic protein-independent low-density lipoprotein receptor-related protein 1-extracellular signal-regulated kinase activation, calcineurin signaling, and low-density lipoprotein receptor-related protein 1β-mediated nuclear factor 45 nuclear export in response to BMPER treatment. CONCLUSIONS: We conclude that BMPER plays a pivotal role in pulmonary inflammatory response, which provides new therapeutic options against sepsis shock. The new signaling pathway initiated by BMPER/low-density lipoprotein receptor-related protein 1 axis broadens our understanding about BMPER's role in vascular homeostasis.
Authors: Deyu Guan; Nihal Altan-Bonnet; Andrew M Parrott; Cindy J Arrigo; Quan Li; Mohammed Khaleduzzaman; Hong Li; Chee-Gun Lee; Tsafi Pe'ery; Michael B Mathews Journal: Mol Cell Biol Date: 2008-05-05 Impact factor: 4.272
Authors: Rajesh Kumar Gandhirajan; Shu Meng; Harish C Chandramoorthy; Karthik Mallilankaraman; Salvatore Mancarella; Hui Gao; Roshanak Razmpour; Xiao-Feng Yang; Steven R Houser; Ju Chen; Walter J Koch; Hong Wang; Jonathan Soboloff; Donald L Gill; Muniswamy Madesh Journal: J Clin Invest Date: 2013-01-25 Impact factor: 14.808
Authors: Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty Journal: Arterioscler Thromb Vasc Biol Date: 2018-10 Impact factor: 8.311
Authors: Dianaly T Au; Allison L Arai; William E Fondrie; Selen C Muratoglu; Dudley K Strickland Journal: Curr Drug Targets Date: 2018 Impact factor: 3.465